Disclaimer This presentation contains forward looking statements. Any statements contained in this presentation that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995, as amended, including without limitation: implied and express statements regarding the clinical development of Molecular Partners' current or future product candidates; expectations regarding timing for reporting data from ongoing clinical ...

Fourth Quarter 2025 Earnings Presentation Contents Contents Performance Highlights Financial Highlights Operational Highlights Appendix Performance Highlights Performance Highlights Net Revenues 1,141 5.4 RMB million Gross Profit 358 RMB million 158 RMB million 2025 Q4 By harmonizing organic business development with targeted strategic investment, we have established a resilient framework for scale. Effective execution drove meaningful progress in our international expansion, while intensified customs enfor ...

VEON Delivers Record Digital Growth Revenues +9.9% in 2025, +17.4% in 4Q25 EBITDA +18.8% in 2025, +29.1% in 4Q25 Digital Revenues +63% in 2025, +84% in 4Q25 13 March 2026 | FY25 & 4Q25 Results Presentation DISCLAIMER Notice To Readers Certain of VEON's results and other financial information presented in this document are, unless otherwise stated, prepared in accordance with International Financial Reporting Standards ("IFRS") as issued by the international Accounting Standards Board and have not been exter ...

Savara Inc. ("Savara" or the "Company") cautions you that statements in this presentation that are not a description of historical fact are forward-looking statements which may be identified by the use of words such as "expect," "intend," "plan," "anticipate," "believe," and "will," among others. Such statements include, but are not limited to, statements regarding the potential health benefits and risks and projected development timeline of MOLBREEVI; the timing of regulatory submissions; the potential for ...

OWENS CORNING Q1 2026 INVESTOR PRESENTATION This presentation shared at the following events: | 03/11/26 | IR Roadshow Hosted by Deutsche Bank – Baltimore | | --- | --- | | | Brian Chambers, Chair & Chief Executive Officer | | 03/05/26 | Wolfe Research Housing Conference – New York | | | Todd Fister, Chief Financial Officer | | 03/04/26 | Evercore ISI Housing and Building Products Symposium – New York | | | Todd Fister, Chief Financial Officer | TM FORWARD-LOOKING STATEMENTS AND NON-GAAP MEASURES This prese ...

Barinthus Biotherapeutics Corporate Presentation Guiding the Immune System to Cure Disease March 2026 Nasdaq: BRNS Disclosure Cautionary Statement Regarding Forward-Looking Statements This presentation contains forward-looking statements within the meaning of federal securities laws, including the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based upon current plans, estimates and expectations of management of Clywedog and Barinthus Bio, in light of h ...

Fourth Quarter 2025 Financial Results March 13, 2026 1 Trademark of Trinseo PLC or its affiliates Disclosure Rules Disclosure Rules This presentation may contain forward-looking statements including, without limitation, statements concerning plans, objectives, goals, projections, forecasts, strategies, future events or performance, and underlying assumptions and other statements, which are not statements of historical facts. Forward-looking statements may be identified by the use of words like "expect," "an ...

Northern Star Resources Conference Call Summary Company Overview - **Company**: Northern Star Resources (OTCPK:NESR.F) - **Date of Call**: March 12, 2026 Key Points Production Guidance and Challenges - The company anticipates FY26 production to be above **1.5 million ounces**, despite a weaker production performance quarter to date, making full-year guidance challenging [2][8] - Operational challenges at the **Fimiston processing plant** have led to a revised throughput estimate of **10 million tons** for FY26, down from the planned **12 million tons** [3][4] - Stockpiled high-grade ore at the end of February totaled approximately **2 million tons** at **1.6 grams per ton**, equating to **100,000 ounces** [3] Operational Reviews and Cost Management - An operational review is underway at the **Yandal Hub** to reduce costs and prioritize higher-margin ounces due to high-cost production [4][5] - The **Jundee** operation is becoming more capital intensive, prompting a review to redeploy surplus personnel and equipment to higher-margin operations [5] - The company is committed to balancing preventative maintenance tasks to mitigate disruptions until the new plant is commissioned in early FY27 [4] KCGM and Jundee Performance - The **KCGM** mill is underperforming, with a throughput rate expected to be nearly **9 million tons** for the second half of FY26, impacting overall production [8][9] - The bulk of the production shortfall is attributed to KCGM, with **two-thirds** of the lower ounces coming from this site [20][22] - Jundee's operational review is critical, as the asset is not meeting planned grades, and a reset is needed to align with production targets [11][31] Future Outlook and Medium-Term Forecasts - The company plans to release medium-term forecasts by the end of the calendar year, focusing on multi-year production costs and capital [5][54] - The new Fimiston plant is on track for commissioning in FY27, with expectations for a ramp-up to **23 million tons** for that year [49][50] Financial Considerations - Year-to-date all-in sustaining costs (AISC) are tracking within the guidance of **$2,600-$2,800** [26] - The company is free cash flow positive for January and February, with expectations for continued positive cash flow in the upcoming months [95] Strategic Considerations - The management acknowledges the need to improve guidance accuracy and prevent future downgrades, emphasizing the importance of stability in operations [87][88] - There is a recognition of vulnerability regarding stock performance relative to global peers, and the board is actively discussing strategies to enhance company value [101] Additional Insights - The aging infrastructure at KCGM is causing significant downtime, with **30%** of downtime attributed to bogging events and **20-30%** to electrical issues [39][40] - The company is focused on ensuring that the new plant's commissioning does not compromise current production targets [42][43] Conclusion Northern Star Resources is navigating significant operational challenges, particularly at KCGM and Jundee, which are impacting production guidance. The company is undertaking strategic reviews and operational adjustments to enhance performance and align with future production targets. The upcoming commissioning of the new Fimiston plant is a critical milestone for the company, with expectations for improved throughput and efficiency in FY27.

Accelerating the energy transition INVESTOR PRESENTATION March 2026 TSX: GRN | FSE: 52G | OTC: GRNWF TSX: GRN / FSE: 52G / OTC: GRNWF Important Disclosures Available Information Greenlane Renewables Inc. (the "Company") is a public company which is traded on the TSX (TSX: GRN), with its principal office in Vancouver, British Columbia, Canada. This Presentation is for informational purposes and is not an offer to sell or a solicitation of an offer to buy any securities in the Company and may not be relied up ...

Financial Data and Key Metrics Changes - Fiscal 2026 first quarter revenue totaled $278.6 million, down 17% from the prior year, driven by a 30% decrease in pricing due to higher industry supply [17] - Despite lower revenue, gross profit remained consistent at $31.6 million, leading to a gross margin increase of 190 basis points to 11.3% compared to the same period last year [17][18] - Adjusted EBITDA increased 5% to $18.5 million compared to $17.7 million last year, driven by higher avocado volume sold and improved per unit margins [21] Business Line Data and Key Metrics Changes - Marketing and Distribution segment net sales decreased 21% to $234.8 million, but adjusted EBITDA increased 33% to $12.9 million, reflecting higher avocado volume sold and solid per unit margins [21] - International Farming segment total sales increased 15% to $10.6 million, with adjusted EBITDA rising 28% to $2.3 million due to improved pack house utilization [22] - Blueberry segment total sales increased 12% to $40.8 million, but adjusted EBITDA decreased to $3.3 million due to lower per acre yields [23] Market Data and Key Metrics Changes - Mexican supply was abundant this quarter, with higher yields in the current harvest season compared to last year, contributing to a 14% growth in avocado volumes [6][17] - Household penetration of avocados reached approximately 72%, with per capita consumption nearly tripling over the past two decades, indicating strong demand trends [8] Company Strategy and Development Direction - The company is focused on leveraging the Calavo acquisition to enhance its core avocado business and expand into prepared foods, which is seen as a strategic opportunity [10][12] - Integration planning for the Calavo acquisition is underway, with expectations of achieving at least $25 million in annualized cost synergies within 18 months of closing [14] - The company aims to balance reinvestment in the business with returning capital to shareholders as free cash flow ramps up [15][49] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the underlying strength of the business model despite near-term pricing pressures, emphasizing the long-term growth potential in avocado consumption [28] - The company anticipates a lower pricing environment in the second quarter, with expected avocado industry volumes increasing by approximately 10%-15% [25][26] - Management highlighted the importance of maximizing productivity and strengthening customer partnerships to drive long-term value creation [28] Other Important Information - SG&A expenses increased by $6.9 million, or 31%, primarily due to transaction advisory costs associated with the Calavo acquisition [18] - Cash and cash equivalents were $44.8 million as of January 31, 2026, down from $64.8 million as of October 31, 2025 [24] Q&A Session Summary Question: Insights on Calavo acquisition and synergy realization - Management feels confident about the $25 million synergy estimate and sees opportunities for further upside, focusing on cost-related synergies and growth potential [31][33] Question: Impact of pricing environment on margins - Management acknowledged that while lower prices compress margins, the focus remains on maintaining profitability through volume and per unit margins [39][41] Question: Timeline for blueberry farms reaching full productivity - Management expects blueberry farms to reach full productivity within 12-18 months, with improved yields anticipated as the plants mature [45][47] Question: Long-term capital allocation strategy - Management is committed to balancing debt management, reinvestment in growth, and returning capital to shareholders, with discussions ongoing about shareholder returns [49][51]